Endovenous laser ablation for saphenous vein insufficiency: Short- and mid-term results of 230 procedures

Objective The present study aimed to evaluate the efficacy of endovenous laser ablation with a 1470-nm laser and to analyze the short- to mid-term results of endovenous laser ablation procedures to treat great saphenous vein insufficiency. Method In this retrospective study, 200 patients (230 limbs)...

Full description

Saved in:
Bibliographic Details
Published in:Vascular 2015-02, Vol.23 (1), p.3-8
Main Authors: Altin, Firat H, Aydin, Selim, Erkoc, Kamuran, Gunes, Tevfik, Eygi, Bortecin, Kutas, Baris H
Format: Article
Language:English
Subjects:
Adult
Female
Humans
Laser Therapy - adverse effects
Male
Middle Aged
Retrospective Studies
Saphenous Vein - surgery
Severity of Illness Index
Time Factors
Treatment Outcome
Varicose Veins - diagnosis
Varicose Veins - surgery
Venous Insufficiency - diagnosis
Venous Insufficiency - surgery
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective The present study aimed to evaluate the efficacy of endovenous laser ablation with a 1470-nm laser and to analyze the short- to mid-term results of endovenous laser ablation procedures to treat great saphenous vein insufficiency. Method In this retrospective study, 200 patients (230 limbs) with symptomatic varicose veins secondary to great saphenous vein insufficiency treated with 1470-nm endovenous laser ablation were studied. Patients were evaluated clinically on the first day, first week, first month, and sixth month after the operation. Treated limbs were evaluated as separate treatment events. Results The short-term occlusion rate was 99% and mid-term occlusion rate was 100%. Induration or swelling was the most common minor complication (13%). No major complication such as deep venous thrombosis and pulmonary embolus occurred. Preoperatively documented mean venous clinical severity score significantly reduced from 4.9 ± 2.3 to 2.5 ± 1.1 (p 
ISSN:1708-5381
1708-539X
DOI:10.1177/1708538114522997